Pleural Pseudomyxoma Secondary to Appendiceal Mucinous Adenocarcinoma: A Case Report
Case Reports in Oncology · 09.06.2026 · 19 (1) · 1021-1028
DOI: 10.1159/000552854 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 09.06.2026. Verfasst von Mohammad Hossein Teymoori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Appendiceal mucinous neoplasms are uncommon gastrointestinal tumors. In some cases, they evolve into pseudomyxoma peritonei (PMP), a condition characterized by mucinous ascites and peritoneal dissemination. Treatment typically requires comprehensive cytoreductive surgery (CRS), commonly combined with hyperthermic intraperitoneal chemotherapy (HIPEC). While PMP usually remains confined to the abdominal cavity, extra-abdominal spread is exceptional. Pleural involvement, often described as pleural pseudomyxoma, has been reported only rarely. Case Presentation: We report the case of a 55-year-old man who was initially diagnosed with PMP arising from a well-differentiated mucin-producing adenocarcinoma of the appendix. He underwent CRS with splenectomy without HIPEC because of financial and technical limitations. Approximately 1 year later, he developed progressive dyspnea and cough. Imaging revealed left pleural effusion with nodular pleural thickening and mucinous densities. Video-assisted thoracoscopic surgery demonstrated mucinous pleural deposits, and histopathological examination confirmed metastatic well-differentiated mucinous adenocarcinoma involving the pleura. He underwent thoracoscopic pleural debulking followed by systemic chemotherapy, with short-term disease stability.
Conclusion
Pleural pseudomyxoma represents an exceedingly rare thoracic extension of appendiceal PMP. Although CRS-HIPEC remains the preferred treatment strategy for selected patients in specialized centers, individualized thoracoscopic debulking combined with systemic chemotherapy may provide short- to intermediate-term disease control in resource-limited settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
- General Surgery Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Hazrat Rasool Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Surgery, Iran University of Medical Sciences, Firoozgar Hospital, Tehran, Iran.
Zitieren
APA
Teymoori, M. H., Gandomi-Mohammadabadi, A., Ramezani, A., Asgari Soran, N., Maleki, M., & Baghai Wadji, M. (2026). Pleural Pseudomyxoma Secondary to Appendiceal Mucinous Adenocarcinoma: A Case Report. Case Reports in Oncology, 19(1), 1021-1028. https://doi.org/10.1159/000552854
Vancouver
Teymoori MH, Gandomi-Mohammadabadi A, Ramezani A, Asgari Soran N, Maleki M, Baghai Wadji M. Pleural Pseudomyxoma Secondary to Appendiceal Mucinous Adenocarcinoma: A Case Report. Case Reports in Oncology. 2026;19(1):1021-1028. doi:10.1159/000552854
BibTeX
@article{Teymoori2026,
author = {Teymoori, Mohammad Hossein and Gandomi-Mohammadabadi, Alireza and Ramezani, Alireza and Asgari Soran, Nasrin and Maleki, Masoud and Baghai Wadji, Massoud},
title = {Pleural Pseudomyxoma Secondary to Appendiceal Mucinous Adenocarcinoma: A Case Report},
journal = {Case Reports in Oncology},
year = {2026},
volume = {19},
number = {1},
pages = {1021--1028},
doi = {10.1159/000552854}
}
EUVIMED